Kura Oncology Inc (NASDAQ: KURA) is 10.64% higher on its value in year-to-date trading and has touched a low of $9.06 and a high of $24.17 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The KURA stock was last observed hovering at around $15.96 in the last trading session, with the day’s loss setting it -0.05%.
Currently trading at $15.91, the stock is -7.44% and -12.95% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.63 million and changing -0.31% at the moment leaves the stock -20.57% off its SMA200. KURA registered 66.60% gain for a year compared to 6-month loss of -29.45%. The firm has a 50-day simple moving average (SMA 50) of $18.3558 and a 200-day simple moving average (SMA200) of $20.055225.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -8.41% gain in the last 1 month and extending the period to 3 months gives it a -19.40%, and is -10.37% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.07% over the week and 5.35% over the month.
Kura Oncology Inc (KURA) has around 142 employees, a market worth around $1.24B and $0.00M in sales. Distance from 52-week low is 75.61% and -34.17% from its 52-week high. The company has generated returns on investments over the last 12 months (-45.21%).
The EPS is expected to shrink by -18.07% this year
254.0 institutions hold shares in Kura Oncology Inc (KURA), with institutional investors hold 109.36% of the company’s shares. The shares outstanding are 74.35M, and float is at 65.07M with Short Float at 16.60%. Institutions hold 108.21% of the Float.
The top institutional shareholder in the company is SUVRETTA CAPITAL MANAGEMENT, LLC with over 7.07 million shares valued at $145.56 million. The investor’s holdings represent 8.4258 of the KURA Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 6.97 million shares valued at $143.43 million to account for 8.302 of the shares outstanding. The other top investors are ECOR1 CAPITAL, LLC which holds 5.81 million shares representing 6.9208 and valued at over $119.56 million, while DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) holds 6.4496 of the shares totaling 5.41 million with a market value of $111.42 million.
Kura Oncology Inc (KURA) Insider Activity
The most recent transaction is an insider sale by FORD KATHLEEN, the company’s Chief Operating Officer. SEC filings show that FORD KATHLEEN sold 526 shares of the company’s common stock on Nov 18 ’24 at a price of $16.03 per share for a total of $8434.0. Following the sale, the insider now owns 23184.0 shares.
Still, SEC filings show that on May 20 ’24, Bair Teresa Brophy (Chief Legal Officer) disposed off 2,615 shares at an average price of $22.15 for $57916.0. The insider now directly holds 68,979 shares of Kura Oncology Inc (KURA).
